Insights from 2023 ASH Annual Meeting


 

ASH 2023 Insights: "HR-QOL in Adults With Hemophilia B Treated With Fidanacogene Elaparvovec Gene Therapy"

15 views
January 16, 2024
0 Comments
Login to view comments. Click here to Login
Benign Hematology